Skip to main content
Top
Published in: Clinical Rheumatology 12/2008

01-12-2008 | Original Article

Primary Sjögren’s syndrome in men: clinical and immunological characteristic based on a large cohort of Hungarian patients

Authors: Ildiko Fanny Horvath, Peter Szodoray, Margit Zeher

Published in: Clinical Rheumatology | Issue 12/2008

Login to get access

Abstract

The aim of the study was to define main symptoms of clinical appearance and immunoserological profile of male patients with primary Sjögren’s syndrome (pSS). Four hundred and ninety-two patients fulfilling the European–American Consensus Criteria for pSS were involved in this study. The mean age of the patients was 55.93 years (55.67 years in women and 56.18 years in men). The female–male ratio was 7:1 (432 and 60 patients, respectively). At the time of the diagnosis of pSS, glandular, extraglandular manifestations (EGMs), and immunoserological parameters were assessed. The major EGMs differ between genders. Arthritis was frequently presented as EGM in both genders, but the ratio was higher in men (68% vs. 42%). Various vasculitis symptoms and lymphadenopathy were more frequent in men than in women, in contrast to Raynaud’s phenomenon or autoimmune thyroiditis. Anti-SS-A and anti-SS-B were the most frequent autoantibodies in both genders, although autoantibodies against anti-nuclear factor and extractable nuclear antigens also presented in some patients. In a few cases, there were other specific autoantibodies correlated with EGMs, such as double-stranded DNA, anti-neutrophilic–cytoplasmic antibody, cyclic-citrullinated peptide, anti-thyreoglobuline antibodies, and anti-thyreoid-peroxidase antibodies. Based upon our large cohort of patients with pSS, we conclude that, although the disease is more frequent in women usually about climax, it develops also in men with the predominant symptoms of vasculitis or arthritis besides keratoconjunctivitis sicca or xerostomy.
Literature
2.
go back to reference Jonsson R, Moen K, Vestrheim D et al (2002) Current issues in Sjögren’s syndrome. Oral Dis 8:130–140PubMedCrossRef Jonsson R, Moen K, Vestrheim D et al (2002) Current issues in Sjögren’s syndrome. Oral Dis 8:130–140PubMedCrossRef
3.
go back to reference Márton K, Boros I, Varga G et al (2006) Evaluation of palatal saliva flow rate and oral manifestations in patients with Sjögren’s syndrome. Oral Dis 12:480–486PubMedCrossRef Márton K, Boros I, Varga G et al (2006) Evaluation of palatal saliva flow rate and oral manifestations in patients with Sjögren’s syndrome. Oral Dis 12:480–486PubMedCrossRef
4.
go back to reference Csepregi A, Szodoray P, Zeher M (2002) Do autoantibodies predict autoimmune liver disease in primary Sjögren’s syndrome? Data of 180 patients upon a 5 year follow-up. Scand J Immunol 56:623–629PubMedCrossRef Csepregi A, Szodoray P, Zeher M (2002) Do autoantibodies predict autoimmune liver disease in primary Sjögren’s syndrome? Data of 180 patients upon a 5 year follow-up. Scand J Immunol 56:623–629PubMedCrossRef
5.
go back to reference Szodoray P, Barta Z, Lakos G et al (2004) Coeliac disease in Sjögren’s syndrome—a study of 111 Hungarian patients. Rheumatol Int 24:278–282PubMedCrossRef Szodoray P, Barta Z, Lakos G et al (2004) Coeliac disease in Sjögren’s syndrome—a study of 111 Hungarian patients. Rheumatol Int 24:278–282PubMedCrossRef
6.
go back to reference Fox RI, Kang HI (1992) Pathogenesis of Sjögren’s syndrome. Rheum Dis Clin North Am 18:517–538PubMed Fox RI, Kang HI (1992) Pathogenesis of Sjögren’s syndrome. Rheum Dis Clin North Am 18:517–538PubMed
7.
go back to reference Mikulicz J (1888) Discussion at Verein fur wissenschaftliche Heilkunde zu königsberg. Berl Klin Wocchenschr 25:759 Mikulicz J (1888) Discussion at Verein fur wissenschaftliche Heilkunde zu königsberg. Berl Klin Wocchenschr 25:759
8.
go back to reference Parke AL (2000) Sjogren’s syndrome: a women’s health problem. J Rheumatol Suppl 61:4–5PubMed Parke AL (2000) Sjogren’s syndrome: a women’s health problem. J Rheumatol Suppl 61:4–5PubMed
9.
go back to reference Anaya JM, Lin GT, D’Souza E (1995) Primary Sjogren’s syndrome in men. Ann Rheum Dis 54:748–751PubMedCrossRef Anaya JM, Lin GT, D’Souza E (1995) Primary Sjogren’s syndrome in men. Ann Rheum Dis 54:748–751PubMedCrossRef
10.
go back to reference Drosos AA, Tsiakou EK (1997) Subgroups of primary Sjögren’s syndrome. Sjögren’s syndrome in male and paediatric Greek patients. Ann Rheum Dis 56:333–335PubMed Drosos AA, Tsiakou EK (1997) Subgroups of primary Sjögren’s syndrome. Sjögren’s syndrome in male and paediatric Greek patients. Ann Rheum Dis 56:333–335PubMed
11.
go back to reference Brennan MT, Fox PC (1999) Sex differences in primary Sjogren’s syndrome. J Rheumatol 26:2373–2376PubMed Brennan MT, Fox PC (1999) Sex differences in primary Sjogren’s syndrome. J Rheumatol 26:2373–2376PubMed
12.
go back to reference Molina R, Provost TT, Arnett FC (1986) Primary Sjogren’s syndrome in men. Clinical, serologic, and immunogenetic features. Am J Med 80:23–31PubMedCrossRef Molina R, Provost TT, Arnett FC (1986) Primary Sjogren’s syndrome in men. Clinical, serologic, and immunogenetic features. Am J Med 80:23–31PubMedCrossRef
13.
go back to reference Yazawa Y, Okada K, Fukui J et al (1997) Clinical features of Sjögren syndrome. Nippon Jibiinkoka Gakkai Kaiho 100:429–435PubMed Yazawa Y, Okada K, Fukui J et al (1997) Clinical features of Sjögren syndrome. Nippon Jibiinkoka Gakkai Kaiho 100:429–435PubMed
14.
go back to reference Cervera R, Font J, Ramos-Casals M (2000) Primary Sjogren’s syndrome in men: clinical and immunological characteristics. Lupus 9:61–64PubMedCrossRef Cervera R, Font J, Ramos-Casals M (2000) Primary Sjogren’s syndrome in men: clinical and immunological characteristics. Lupus 9:61–64PubMedCrossRef
15.
go back to reference Diaz-Lopez C, Geli C, Corominas H (2004) Are there clinical or serological differences between male and female patients with primary Sjogren’s syndrome. J Rheumatol 31:1352–1355PubMed Diaz-Lopez C, Geli C, Corominas H (2004) Are there clinical or serological differences between male and female patients with primary Sjogren’s syndrome. J Rheumatol 31:1352–1355PubMed
16.
go back to reference Merrill JT, Dinu AR, Lahita RG (1996) Autoimmunity: the female connection. Medscape Womens Health 1:5PubMed Merrill JT, Dinu AR, Lahita RG (1996) Autoimmunity: the female connection. Medscape Womens Health 1:5PubMed
17.
go back to reference Ansar Ahmed S, Penhale WJ, Talal N (1985) Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol 121:531–551PubMed Ansar Ahmed S, Penhale WJ, Talal N (1985) Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol 121:531–551PubMed
18.
go back to reference Lahita RG (1996) The connective tissue diseases and the overall influence of gender. Int J Fertil Menopausal Stud 41:156–165PubMed Lahita RG (1996) The connective tissue diseases and the overall influence of gender. Int J Fertil Menopausal Stud 41:156–165PubMed
19.
go back to reference Lahita RG (1998) Collagen disease: the enemy within. Int J Fertil Womens Med 43:229–234PubMed Lahita RG (1998) Collagen disease: the enemy within. Int J Fertil Womens Med 43:229–234PubMed
20.
go back to reference Rider V, Foster RT, Evans M et al (1998) Gender differences in autoimmune diseases: estrogen increases calcineurin expression in systemic lupus erythematosus. Clin Immunol Immunopathol 89:171–180PubMedCrossRef Rider V, Foster RT, Evans M et al (1998) Gender differences in autoimmune diseases: estrogen increases calcineurin expression in systemic lupus erythematosus. Clin Immunol Immunopathol 89:171–180PubMedCrossRef
21.
go back to reference Cutolo M, Sulli A, Capellino S et al (2004) Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 13:635–638PubMedCrossRef Cutolo M, Sulli A, Capellino S et al (2004) Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 13:635–638PubMedCrossRef
22.
go back to reference Porola P, Laine M, Virkki L et al (2007) The influence of sex steroids on Sjögren’s syndrome. Ann N Y Acad Sci 1108:426–432PubMedCrossRef Porola P, Laine M, Virkki L et al (2007) The influence of sex steroids on Sjögren’s syndrome. Ann N Y Acad Sci 1108:426–432PubMedCrossRef
23.
go back to reference Laine M, Porola P, Udby L et al (2007) Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjögren’s syndrome. Arthritis Rheum 56:2575–2584PubMedCrossRef Laine M, Porola P, Udby L et al (2007) Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjögren’s syndrome. Arthritis Rheum 56:2575–2584PubMedCrossRef
24.
go back to reference Van Vollenhoven RF, McGuire JL (1994) Estrogen, progesterone, and testosterone: can they be used to treat autoimmune diseases. Cleve Clin J Med 61:276–284PubMed Van Vollenhoven RF, McGuire JL (1994) Estrogen, progesterone, and testosterone: can they be used to treat autoimmune diseases. Cleve Clin J Med 61:276–284PubMed
25.
go back to reference Da Silva JA, Hall GM (1992) The effects of gender and sex hormones on outcome in rheumatoid arthritis. Baillieres Clin Rheumatol 6:196–219PubMed Da Silva JA, Hall GM (1992) The effects of gender and sex hormones on outcome in rheumatoid arthritis. Baillieres Clin Rheumatol 6:196–219PubMed
26.
go back to reference Verthelyi D (2001) Sex hormones as immunomodulators in health and disease. Int Immunopharmacol 1:983–993PubMedCrossRef Verthelyi D (2001) Sex hormones as immunomodulators in health and disease. Int Immunopharmacol 1:983–993PubMedCrossRef
27.
Metadata
Title
Primary Sjögren’s syndrome in men: clinical and immunological characteristic based on a large cohort of Hungarian patients
Authors
Ildiko Fanny Horvath
Peter Szodoray
Margit Zeher
Publication date
01-12-2008
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 12/2008
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-008-0944-7

Other articles of this Issue 12/2008

Clinical Rheumatology 12/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.